{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-134487","form_type":"8-K","ticker":"INAB","cik":"0001740279","company_name":"IN8BIO, INC.","filed_at":"2025-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.531137+00:00","generated_at":"2026-05-20T00:03:10.834899+00:00","sec_items":["3.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"IN8bio to effect 1-for-30 reverse stock split effective June 5, 2025","bullets":["Reverse split at 1-for-30 ratio; effective 5:00 p.m. ET on June 5, 2025.","Shares outstanding will reduce from ~103.3M to ~3.4M (subject to fractional share cash-out).","Stock begins trading on Nasdaq on split-adjusted basis June 6, 2025; new CUSIP 45674E208.","Proportionate adjustments to stock options, warrants, and equity plan reserves; no fractional shares issued.","Charter Amendment filed as Exhibit 3.1; authorized by stockholders on May 8, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-134487","json":"https://secwatch.observer/filing/0001193125-25-134487.json","markdown":"https://secwatch.observer/filing/0001193125-25-134487.md","text":"https://secwatch.observer/filing/0001193125-25-134487.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1740279/000119312525134487/0001193125-25-134487-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1740279/000119312525134487/d927529d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T00:03:10.834899+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}